rs2303428

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000251.3(MSH2):​c.2006-6T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.105 in 1,613,162 control chromosomes in the GnomAD database, including 10,593 homozygotes. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.089 ( 958 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9635 hom. )

Consequence

MSH2
NM_000251.3 splice_region, intron

Scores

2
Splicing: ADA: 0.9081
1
1

Clinical Significance

Benign reviewed by expert panel B:27

Conservation

PhyloP100: 1.45

Publications

85 publications found
Variant links:
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
MSH2 Gene-Disease associations (from GenCC):
  • Lynch syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, G2P
  • Lynch syndrome 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Muir-Torre syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, G2P
  • mismatch repair cancer syndrome 1
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • mismatch repair cancer syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • ovarian cancer
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • malignant pancreatic neoplasm
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • prostate cancer
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • breast cancer
    Inheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 2-47476361-T-C is Benign according to our data. Variant chr2-47476361-T-C is described in ClinVar as Benign. ClinVar VariationId is 36571.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.327 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000251.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
NM_000251.3
MANE Select
c.2006-6T>C
splice_region intron
N/ANP_000242.1P43246-1
MSH2
NM_001406674.1
c.2006-6T>C
splice_region intron
N/ANP_001393603.1
MSH2
NM_001406631.1
c.2006-6T>C
splice_region intron
N/ANP_001393560.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MSH2
ENST00000233146.7
TSL:1 MANE Select
c.2006-6T>C
splice_region intron
N/AENSP00000233146.2P43246-1
MSH2
ENST00000406134.5
TSL:1
c.2006-6T>C
splice_region intron
N/AENSP00000384199.1E9PHA6
MSH2
ENST00000918107.1
c.2057-6T>C
splice_region intron
N/AENSP00000588166.1

Frequencies

GnomAD3 genomes
AF:
0.0890
AC:
13536
AN:
152086
Hom.:
960
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0260
Gnomad AMI
AF:
0.0252
Gnomad AMR
AF:
0.103
Gnomad ASJ
AF:
0.0894
Gnomad EAS
AF:
0.341
Gnomad SAS
AF:
0.143
Gnomad FIN
AF:
0.100
Gnomad MID
AF:
0.0541
Gnomad NFE
AF:
0.100
Gnomad OTH
AF:
0.0947
GnomAD2 exomes
AF:
0.115
AC:
28906
AN:
251186
AF XY:
0.116
show subpopulations
Gnomad AFR exome
AF:
0.0214
Gnomad AMR exome
AF:
0.0793
Gnomad ASJ exome
AF:
0.0949
Gnomad EAS exome
AF:
0.355
Gnomad FIN exome
AF:
0.105
Gnomad NFE exome
AF:
0.0995
Gnomad OTH exome
AF:
0.108
GnomAD4 exome
AF:
0.106
AC:
155365
AN:
1460956
Hom.:
9635
Cov.:
32
AF XY:
0.107
AC XY:
77935
AN XY:
726842
show subpopulations
African (AFR)
AF:
0.0214
AC:
716
AN:
33470
American (AMR)
AF:
0.0806
AC:
3606
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0968
AC:
2529
AN:
26126
East Asian (EAS)
AF:
0.312
AC:
12379
AN:
39680
South Asian (SAS)
AF:
0.133
AC:
11469
AN:
86244
European-Finnish (FIN)
AF:
0.111
AC:
5921
AN:
53388
Middle Eastern (MID)
AF:
0.0988
AC:
570
AN:
5768
European-Non Finnish (NFE)
AF:
0.100
AC:
111239
AN:
1111206
Other (OTH)
AF:
0.115
AC:
6936
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
6787
13575
20362
27150
33937
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4206
8412
12618
16824
21030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0889
AC:
13534
AN:
152206
Hom.:
958
Cov.:
32
AF XY:
0.0919
AC XY:
6841
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0260
AC:
1080
AN:
41542
American (AMR)
AF:
0.103
AC:
1580
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0894
AC:
310
AN:
3468
East Asian (EAS)
AF:
0.340
AC:
1760
AN:
5172
South Asian (SAS)
AF:
0.143
AC:
690
AN:
4822
European-Finnish (FIN)
AF:
0.100
AC:
1064
AN:
10598
Middle Eastern (MID)
AF:
0.0479
AC:
14
AN:
292
European-Non Finnish (NFE)
AF:
0.100
AC:
6810
AN:
67998
Other (OTH)
AF:
0.0961
AC:
203
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
606
1212
1819
2425
3031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
158
316
474
632
790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0790
Hom.:
348
Bravo
AF:
0.0840
Asia WGS
AF:
0.216
AC:
750
AN:
3478
EpiCase
AF:
0.100
EpiControl
AF:
0.0981

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
7
Lynch syndrome 1 (7)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
3
Lynch syndrome (3)
-
-
3
not provided (3)
-
-
1
Hereditary nonpolyposis colorectal neoplasms (1)
-
-
1
Mismatch repair cancer syndrome 1 (1)
-
-
1
Muir-Torré syndrome;C2936783:Lynch syndrome 1;C5436806:Mismatch repair cancer syndrome 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
17
DANN
Benign
0.85
PhyloP100
1.5
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.91
dbscSNV1_RF
Pathogenic
0.72
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2303428; hg19: chr2-47703500; COSMIC: COSV51876931; COSMIC: COSV51876931; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.